{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T19:16:31Z","timestamp":1791832591802,"version":"4.3.4"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T00:00:00Z","timestamp":1569456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009448","name":"Universit\u00e0 degli Studi della Campania Luigi Vanvitelli","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009448","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2019.01117","type":"journal-article","created":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T09:44:00Z","timestamp":1569491040000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["Morphological and Functional Evaluation of Oral Citicoline Therapy in Chronic Open-Angle Glaucoma Patients: A Pilot Study With a 2-Year Follow-Up"],"prefix":"10.3389","volume":"10","author":[{"given":"Michele","family":"Lanza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugo Antonello","family":"Gironi Carnevale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Mele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Bifani Sconocchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Bartollino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciro","family":"Costagliola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,9,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/01.ijg.0000195932.48288.97","article-title":"Enhanced Glaucoma Staging System (GSS 2) for classifying functional damage in glaucoma","volume":"15","author":"Brusini","year":"2006","journal-title":"J. Glaucoma"},{"key":"B2","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1080\/01616412.1995.11740327","article-title":"Citicoline (CDP-choline): mechanisms of action and effects in ischemic brain injury","volume":"17","author":"D\u2019Orlando","year":"1995","journal-title":"Neurol. Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1517\/13543784.2011.579901","article-title":"Medical treatment of glaucoma: present and future","volume":"20","author":"Foganolo","year":"2011","journal-title":"Exp. Opin. Investing Drugs"},{"key":"B4","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s40263-014-0144-8","article-title":"Neuroprotective properties of citicoline: facts, doubts and unresolved issues","volume":"28","author":"Grieb","year":"2014","journal-title":"CNS Drugs"},{"key":"B5","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/jnr.10129","article-title":"Pharmacodynamics of citicoline relevant to the treatment of glaucoma","volume":"67","author":"Grieb","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1136\/bjo.2005.086769","article-title":"Human glaucoma and neural degeneration in intracranial optic nerve, lateral geniculate nucleus, and visual cortex","volume":"90","author":"Gupta","year":"2006","journal-title":"Br. J. Ophthalmol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1097\/ICU.0b013e3280895aea","article-title":"Glaucoma as a neurodegenerative disease","volume":"18","author":"Gupta","year":"2007","journal-title":"Curr. Opin. Ophthalmol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","article-title":"Reduction of intraocular pressure and glaucoma progression; results from the early manifest glaucoma trial","volume":"120","author":"Heijl","year":"2002","journal-title":"Arch. Ophthalmol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"410","DOI":"10.5301\/ejo.5000576","article-title":"Influence of a new software version of the RTVue-100 optical coherence tomograph on the detection of glaucomatous structural progression","volume":"25","author":"Holl\u00f3","year":"2015","journal-title":"Eur. J. Ophthalmol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1097\/IJG.0000000000000290","article-title":"Evaluation of a new software version of the RTVue optical coherence tomograph for image segmentation and detection of glaucoma in high myopia","volume":"25","author":"Holl\u00f3","year":"2016","journal-title":"J. Glaucoma"},{"key":"B11","first-page":"887","article-title":"Glaucoma is second leading cause of blindness globally","volume":"82","author":"Kingman","year":"2004","journal-title":"Bull. World Health Organ."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1016\/j.ophtha.2015.07.027","article-title":"Rates of retinal nerve fiber layer loss in contralateral eyes of glaucoma patients with unilateral progression by conventional methods","volume":"122","author":"Liu","year":"2015","journal-title":"Ophthalmology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1136\/bmj.38506.594977.E0","article-title":"Treatment of intraocular hypertension and glaucoma: meta-analysis of randomized clinical trials","volume":"331","author":"Maier","year":"2005","journal-title":"BMJ"},{"key":"B14","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/ICU.0000000000000231","article-title":"Optical coherence tomography platforms and parameters for glaucoma diagnosis and progression","volume":"27","author":"Mwanza","year":"2016","journal-title":"Curr. Opin. Ophthalmol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"6344","DOI":"10.1167\/iovs.15-17248","article-title":"Residual and dynamic range of retinal nerve fiber layer thickness in glaucoma: comparison of three OCT platforms","volume":"56","author":"Mwanza","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1136\/bjophthalmol-2014-305745","article-title":"Retinal nerve fiber layer thickness floor and corresponding functional loss in glaucoma","volume":"99","author":"Mwanza","year":"2015","journal-title":"Br. J. Ophthalmol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1097\/00001756-200211150-00023","article-title":"Citicoline has a protective effect on damaged retinal ganglion cells in mouse culture retina","volume":"13","author":"Oshitari","year":"2002","journal-title":"Neuroreport"},{"key":"B18","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1159\/000350496","article-title":"Citicoline oral solution in glaucoma: is there a role in slowing disease progression","volume":"229","author":"Ottobelli","year":"2013","journal-title":"Ophthalmologica"},{"key":"B19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10633-005-7348-7","article-title":"Electrophysiological assessment of glaucomatous visual dysfunction during treatment with cytidine-5\u2032-diphosphocholine (citicoline): a study of 8 years of follow-up","volume":"110","author":"Parisi","year":"2005","journal-title":"Doc. Ophthalmol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S0079-6123(08)01137-0","article-title":"Evidence of neuroprotective role of citocoline in glaucoma patients","volume":"173","author":"Parisi","year":"2008","journal-title":"Prog. Brain Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1007\/s00417-015-3044-9","article-title":"Treatment with citicoline eye drops enhances retinal function and neural conduction along the visual pathway in open angle glaucoma","volume":"253","author":"Parisi","year":"2015","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/0002-9394(89)90488-1","article-title":"Retina ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma","volume":"107","author":"Quigley","year":"1989","journal-title":"Am. J. Ophthalmol."},{"key":"B23","first-page":"124","article-title":"Oral citicoline treatment improves visual pathway function in glaucoma","volume":"9","author":"Rejdak","year":"2003","journal-title":"Med. Sci. Monit."},{"key":"B24","doi-asserted-by":"publisher","first-page":"28401","DOI":"10.3390\/ijms161226099","article-title":"Cytidine 5\u2032-diphosphocholine (citicoline) in glaucoma: rationale of its use, current evidence and future perspectives","volume":"16","author":"Roberti","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"B25","first-page":"167","article-title":"Citicoline: update on a promising and widely available agent for neuroprotection and neurorepair","volume":"5","author":"Saver","year":"2008","journal-title":"Rev. Neurol. Dis."},{"key":"B26","first-page":"1","article-title":"Citicoline: pharmacological and clinical review, 2006 update Methods Find","volume":"28","author":"Secades","year":"2006","journal-title":"Exp. Clin. Pharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/nbm.1281","article-title":"Citicoline enhances frontal lobe bioenergetics as measured by phosphorus magnetic resonance spectroscopy","volume":"21","author":"Silveri","year":"2008","journal-title":"NMR Biomed."},{"key":"B28","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/0002-9394(89)90221-3","article-title":"Intraocular pressure and glaucoma","volume":"107","author":"Sommer","year":"1989","journal-title":"Am. J. Ophthalmol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S0002-9394(00)00538-9","article-title":"The relationship between control of intraocular pressure and visual field deterioration. The AIGIS investigators","volume":"130","year":"2000","journal-title":"Am. J. Ophthalmol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.2147\/OPTH.S80445","article-title":"Current perspective of neuroprotection and glaucoma","volume":"9","author":"Tian","year":"2015","journal-title":"Clin. Ophthalmol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/j.1600-0420.2000.tb01107.x","article-title":"The protective effect of citicoline on the progression of the perimetric defects in glaucomatous patients (perimetric study with a 10-year follow-up)","volume":"232","author":"Virno","year":"2000","journal-title":"Acta Ophthalmol. Scand."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/S0140-6736(04)16257-0","article-title":"Primary open angle glaucoma","volume":"363","author":"Weinreb","year":"2004","journal-title":"Lancet"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma","volume":"311","author":"Weinreb","year":"2014","journal-title":"JAMA"},{"key":"B34","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3109\/00952990.2014.925467","article-title":"Citicoline in addictive disorders: a review of the literature","volume":"40","author":"Wignall","year":"2014","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"B35","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S1350-9462(03)00026-0","article-title":"Effects of retinal ganglion cell loss on magno-, parvo-, koniocellular pathways in the lateral geniculate nucleus and visual cortex in glaucoma","volume":"22","author":"Y\u00fccel","year":"2003","journal-title":"Prog. Retin Eye Res."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.01117\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T09:44:05Z","timestamp":1569491045000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.01117\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,26]]},"references-count":35,"alternative-id":["10.3389\/fphar.2019.01117"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2019.01117","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,26]]},"article-number":"1117"}}